ARS Pharmaceuticals, Inc.ARS Pharmaceuticals, Inc.ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc.

No trades
See on Supercharts

SPRY fundamentals

ARS Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The annual and quarterly earnings report below will help you understand the performance of SPRY.

Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q2 '22
Q3 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth